Improvement of Invasive Microvascular Indices Following Guideline-Directed Treatment of Structural Coronary Microvascular Dysfunction: a case report
Clicks: 3
ID: 320937
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
3 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #24 of 251 articles by views in European Heart Journal - Case Reports
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 251 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Background Structural coronary microvascular dysfunction (CMD) is a major pathophysiological mechanism underlying ischaemia with non-obstructive coronary arteries and is associated with persistent angina and impaired functional capacity. Although contemporary European guidelines recommend a structured, stepwise pharmacological approach, invasive confirmation of physiological improvement following this specific treatment protocol remains limited. Case summary An 82-year-old woman presented with typical angina and stress-induced ischaemia on myocardial scintigraphy. Coronary angiography demonstrated a proximal left anterior descending artery stenosis <50% with a fractional flow reserve (FFR) of 0.90. Continuous thermodilution performed in the left anterior descending artery revealed reduced coronary flow reserve (CFR 2.2) and elevated minimal microvascular resistance (798 WU), consistent with structural CMD. A structured, symptom-guided pharmacological optimisation strategy was initiated, including statin therapy, angiotensin-converting enzyme (ACE) inhibition, beta-blockade, calcium-channel blockade, and ranolazine. At four-month follow-up, angina was markedly improved. Repeat invasive assessment in the same coronary territory demonstrated improvement of microvascular indices (CFR 3.8; minimal microvascular resistance 461 WU). Discussion This case illustrates that guideline-directed medical therapy for coronary microvascular dysfunction may be associated with both symptomatic improvement and objective changes in microvascular function.
| Reference Key |
openalex_W7168287913
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Jeremie Buri, Aurelia Zimmerli, Bernard De Bruyne, Thabo Mahendiran, Stephane Fournier |
| Journal | European Heart Journal - Case Reports |
| Year | 2026 |
| DOI |
10.1093/ehjcr/ytag533
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.